Citigroup
ERAS icon

Citigroup’s Erasca ERAS Stock Holding History

Citigroup’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$795K Sell
49,110
-46,660
-49% -$551K ﹤0.01% 3261
2025
Q4 		$356K Buy
95,770
+80,524
+528% +$226K ﹤0.01% 3735
2025
Q3 		$33.2K Sell
15,246
-56,163
-79% -$89.3K ﹤0.01% 4624
2025
Q2 		$90.7K Sell
71,409
-80,820
-53% -$108K ﹤0.01% 4455
2025
Q1 		$209K Sell
152,229
-89,735
-37% -$154K ﹤0.01% 4177
2024
Q4 		$607K Buy
241,964
+107,597
+80% +$295K ﹤0.01% 3690
2024
Q3 		$367K Buy
134,367
+85,666
+176% +$241K ﹤0.01% 3927
2024
Q2 		$115K Buy
48,701
+32,915
+209% +$71K ﹤0.01% 4145
2024
Q1 		$32.5K Buy
15,786
+1,558
+11% +$3.11K ﹤0.01% 4858
2023
Q4 		$30.3K Buy
14,228
+12,162
+589% +$25.6K ﹤0.01% 4801
2023
Q3 		$4.07K Sell
2,066
-34,335
-94% -$88K ﹤0.01% 4768
2023
Q2 		$100K Buy
36,401
+33,102
+1,003% +$94.3K ﹤0.01% 4248
2023
Q1 		$9.93K Sell
3,299
-124,457
-97% -$453K ﹤0.01% 4740
2022
Q4 		$551K Buy
127,756
+44,992
+54% +$305K ﹤0.01% 3098
2022
Q3 		$646K Buy
82,764
+75,278
+1,006% +$606K ﹤0.01% 3044
2022
Q2 		$42K Buy
7,486
+619
+9% +$4.05K ﹤0.01% 4606
2022
Q1 		$59K Sell
6,867
-2,714
-28% -$31.4K ﹤0.01% 4652
2021
Q4 		$149K Buy
9,581
+7,224
+306% +$124K ﹤0.01% 4523
2021
Q3 		$50K Buy
+2,357
New +$48.6K ﹤0.01% 4730

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Citigroup's ERAS Position: Q1 2026 in Review

Citigroup reduced its Erasca (ERAS) stake by 49% in Q1 2026, selling an estimated $551K and leaving 49,110 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #3261.

Citigroup first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Citigroup held 49,110 shares of Erasca worth $795K as of Q1 2026.
  • Citigroup sold 46,660 Erasca shares in Q1 2026, an estimated $551K.
  • Erasca made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3261 holding.
  • Citigroup first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.